<ul>
<li>最近几周，摩根士丹利报告了 2026 年第一季度的盈利超出预期，得益于强劲的顾问收入、稳健的交易表现以及其机构证券和财富管理部门创下的记录业绩，同时宣布将在 2026 年 6 月和 7 月支付的 11 个优先股系列的常规股息。</li>
<li>与此同时，该公司对美国股票和人工智能驱动的盈利趋势持明显乐观态度，强调管理层对其核心业务及支持其财富和投资银行业务的更广泛市场背景的信心。</li>
<li>在盈利超预期和乐观市场前景的背景下，我们将探讨这些发展如何重塑摩根士丹利的投资叙事。</li>
</ul>
<p>寻找 51 家现金流潜力良好但交易价格低于其公允价值的公司。</p>
<h2>摩根士丹利投资叙事回顾</h2>
<p>要拥有摩根士丹利的股票，你必须相信其机构证券和财富管理的组合能够在费用压力、监管和金融科技竞争的情况下继续产生稳健的盈利和资本回报。最新的盈利超预期强化了短期内，关键催化剂仍然是顾问和交易的执行，而最大风险是长期由于向低费用被动产品的转变而导致的利润压力。优先股息的消息并未实质性改变这一风险与回报的平衡。</p>
<p>这里最相关的发展是对 11 个系列的常规优先股息的宣布，以及之前的普通股息和持续的回购。这些举措表明，摩根士丹利仍在向投资者分配大量现金，即使在加大人工智能投资和通过 LTX 和阿布扎比证券交易所等平台扩大市场准入的情况下。对于关注资本回报作为短期催化剂的股东而言，这种一致性是一个重要的数据点。</p>
<p>但在这个相对乐观的图景下，投资者也应意识到，被动投资的急剧加速和费用压缩可能会...</p>
<p>阅读摩根士丹利的完整叙事（免费！）</p>
<p>摩根士丹利的叙事预计到 2029 年收入为 832 亿美元，盈利为 197 亿美元。这需要每年 5.8% 的收入增长和从 162 亿美元增加到 35 亿美元的盈利增长。</p>
<p>揭示摩根士丹利的预测如何得出 190.33 美元的公允价值，与其当前价格一致。</p>
<h2>探索其他视角</h2>
<p><img src="https://imageproxy.pbkrs.com/https://images.simplywall.st/company/0d015bad-cbbd-4193-825d-b6c6f88a429f/chart/quote-price?x-oss-process=image/auto-orient,1/interlace,1/resize,w_1440,h_1440/quality,q_95/format,jpg" alt="" original-src="https://imageproxy.pbkrs.com/https://images.simplywall.st/company/0d015bad-cbbd-4193-825d-b6c6f88a429f/chart/quote-price"/></p>
<p>MS 1 年股票价格走势图</p>
<p>尽管最近的业绩看起来强劲，但最悲观的分析师之前假设到 2029 年的收入约为 797 亿美元，盈利约为 174 亿美元，这反映出比共识更为严峻的观点，并显示出你和其他投资者可能对同样的摩根士丹利新闻有不同的看法。</p>
<p>探索摩根士丹利的其他 4 个公允价值估计——为什么该股票可能比当前价格高出 15%！</p>
<h2>结论由你决定</h2>
<p>不同意现有叙事？非凡的投资回报很少来自随大流，因此请遵循你的直觉。</p>
<ul>
<li>开始你的摩根士丹利研究的一个好起点是我们的分析，突出了 4 个关键回报和 3 个可能影响你投资决策的重要警示信号。</li>
<li>我们的免费摩根士丹利研究报告提供了全面的基本面分析，汇总在一个视觉图中——雪花图，使你能够一目了然地评估摩根士丹利的整体财务健康状况。</li>
</ul>
<h2>摩根士丹利没有机会？</h2>
<p>我们的每日扫描揭示了具有突破潜力的股票。不要错过这个机会：</p>
<ul>
<li>人工智能即将改变医疗保健。这 32 只股票正在从早期诊断到药物发现等各个方面进行研发。最棒的是——它们的市值都在 100 亿美元以下——还有时间提前布局。</li>
<li>揭示 27 只平衡风险和回报的精英便士股票的下一个大机会。</li>
<li>最新的 GPU 需要一种叫做钕的稀土金属，全球只有 30 家公司在探索或生产它。免费获取名单。</li>
</ul>
<p><em>本文由 Simply Wall St 撰写，内容具有一般性。<strong>我们提供基于历史数据和分析师预测的评论，采用无偏见的方法，我们的文章并不旨在提供财务建议。</strong> 这并不构成买入或卖出任何股票的推荐，也未考虑你的目标或财务状况。我们旨在为你提供以基本数据驱动的长期分析。请注意，我们的分析可能未考虑最新的价格敏感公司公告或定性材料。Simply Wall St 在提到的任何股票中没有持仓。</em></p>
<h3><strong>新功能：在一个地方管理所有股票投资组合</strong></h3>
<p>我们为股票投资者创建了 <strong>终极投资组合助手</strong>，<strong>而且是免费的。</strong></p>
<p>• 连接无限数量的投资组合，并以一种货币查看你的总额</p>
<p>• 通过电子邮件或手机接收新的警示信号或风险提示</p>
<p>• 跟踪你股票的公允价值</p>
<p>免费试用演示投资组合</p>

摩根士丹利

PEPS

CVLC

<p>摩根士丹利报告了 2026 年第一季度强劲的盈利超预期，主要得益于顾问收入和交易表现，同时在十一种优先股系列中维持了常规分红。该公司对美国股票和人工智能驱动的盈利趋势持乐观态度，预计到 2029 年收入将达到 832 亿美元，盈利将达到 197 亿美元。尽管面临费用压缩带来的潜在长期风险，但持续向股东回报资本仍然是重点关注。分析师对该股票的公允价值看法不一，有些人认为其价值可能比当前价格高出 15%</p>

<ul>
<li>In recent weeks, Morgan Stanley reported a first-quarter 2026 earnings beat driven by strong advisory revenues, robust trading performance, and record results in its Institutional Securities and Wealth Management divisions, while also declaring regular dividends across eleven preferred stock series payable in June and July 2026.</li>
<li>At the same time, the firm has taken a visibly optimistic stance on U.S. equities and AI-driven earnings trends, underlining management’s confidence in its core businesses and the broader market backdrop supporting its wealth and investment banking franchises.</li>
<li>With this backdrop of an earnings beat and upbeat market outlook, we’ll now examine how these developments reshape Morgan Stanley’s investment narrative.</li>
</ul>
<div class="lb-trans"><ul>
<li>最近几周，摩根士丹利报告了 2026 年第一季度的盈利超出预期，得益于强劲的顾问收入、稳健的交易表现以及其机构证券和财富管理部门创下的记录业绩，同时宣布将在 2026 年 6 月和 7 月支付的 11 个优先股系列的常规股息。</li>
<li>与此同时，该公司对美国股票和人工智能驱动的盈利趋势持明显乐观态度，强调管理层对其核心业务及支持其财富和投资银行业务的更广泛市场背景的信心。</li>
<li>在盈利超预期和乐观市场前景的背景下，我们将探讨这些发展如何重塑摩根士丹利的投资叙事。</li>
</ul>
</div><p>Find 51 companies with promising cash flow potential yet trading below their fair value.</p>
<div class="lb-trans"><p>寻找 51 家现金流潜力良好但交易价格低于其公允价值的公司。</p>
</div><h2>Morgan Stanley Investment Narrative Recap</h2>
<div class="lb-trans"><h2>摩根士丹利投资叙事回顾</h2>
</div><p>To own Morgan Stanley, you have to believe its mix of institutional securities and wealth management can keep generating solid earnings and capital returns despite fee pressure, regulation, and fintech competition. The latest earnings beat reinforces that short term, the key catalyst remains execution in advisory and trading, while the biggest risk is long term margin pressure from shifts toward low fee passive products. The preferred dividend news does not materially change that risk reward balance.</p>
<div class="lb-trans"><p>要拥有摩根士丹利的股票，你必须相信其机构证券和财富管理的组合能够在费用压力、监管和金融科技竞争的情况下继续产生稳健的盈利和资本回报。最新的盈利超预期强化了短期内，关键催化剂仍然是顾问和交易的执行，而最大风险是长期由于向低费用被动产品的转变而导致的利润压力。优先股息的消息并未实质性改变这一风险与回报的平衡。</p>
</div><p>The most relevant development here is the regular preferred dividend declaration across eleven series, alongside earlier common dividends and ongoing buybacks. Together, these moves highlight that Morgan Stanley is still allocating substantial cash to investors even as it ramps up AI initiatives and expands market access through platforms like LTX and Abu Dhabi Securities Exchange. For shareholders focused on capital return as a near term catalyst, this consistency is an important data point.</p>
<div class="lb-trans"><p>这里最相关的发展是对 11 个系列的常规优先股息的宣布，以及之前的普通股息和持续的回购。这些举措表明，摩根士丹利仍在向投资者分配大量现金，即使在加大人工智能投资和通过 LTX 和阿布扎比证券交易所等平台扩大市场准入的情况下。对于关注资本回报作为短期催化剂的股东而言，这种一致性是一个重要的数据点。</p>
</div><p>But against this relatively upbeat picture, investors should also be aware that a sharp acceleration in passive investing and fee compression could...</p>
<div class="lb-trans"><p>但在这个相对乐观的图景下，投资者也应意识到，被动投资的急剧加速和费用压缩可能会...</p>
</div><p>Read the full narrative on Morgan Stanley (it's free!)</p>
<div class="lb-trans"><p>阅读摩根士丹利的完整叙事（免费！）</p>
</div><p>Morgan Stanley's narrative projects $83.2 billion revenue and $19.7 billion earnings by 2029. This requires 5.8% yearly revenue growth and a $3.5 billion earnings increase from $16.2 billion.</p>
<div class="lb-trans"><p>摩根士丹利的叙事预计到 2029 年收入为 832 亿美元，盈利为 197 亿美元。这需要每年 5.8% 的收入增长和从 162 亿美元增加到 35 亿美元的盈利增长。</p>
</div><p>Uncover how Morgan Stanley's forecasts yield a $190.33 fair value, in line with its current price.</p>
<div class="lb-trans"><p>揭示摩根士丹利的预测如何得出 190.33 美元的公允价值，与其当前价格一致。</p>
</div><h2>Exploring Other Perspectives</h2>
<div class="lb-trans"><h2>探索其他视角</h2>
</div><p><img src="https://imageproxy.pbkrs.com/https://images.simplywall.st/company/0d015bad-cbbd-4193-825d-b6c6f88a429f/chart/quote-price" alt="" original-src="https://images.simplywall.st/company/0d015bad-cbbd-4193-825d-b6c6f88a429f/chart/quote-price"/></p>
<p>MS 1-Year Stock Price Chart</p>
<div class="lb-trans"><p>MS 1 年股票价格走势图</p>
</div><p>While recent results look strong, the most pessimistic analysts were previously assuming revenue of about US$79.7 billion and earnings of roughly US$17.4 billion by 2029, which reflects a much tougher view than the consensus and shows how differently you and other investors might see the same Morgan Stanley headlines.</p>
<div class="lb-trans"><p>尽管最近的业绩看起来强劲，但最悲观的分析师之前假设到 2029 年的收入约为 797 亿美元，盈利约为 174 亿美元，这反映出比共识更为严峻的观点，并显示出你和其他投资者可能对同样的摩根士丹利新闻有不同的看法。</p>
</div><p>Explore 4 other fair value estimates on Morgan Stanley - why the stock might be worth as much as 15% more than the current price!</p>
<div class="lb-trans"><p>探索摩根士丹利的其他 4 个公允价值估计——为什么该股票可能比当前价格高出 15%！</p>
</div><h2>The Verdict Is Yours</h2>
<div class="lb-trans"><h2>结论由你决定</h2>
</div><p>Disagree with existing narratives? Extraordinary investment returns rarely come from following the herd, so go with your instincts.</p>
<div class="lb-trans"><p>不同意现有叙事？非凡的投资回报很少来自随大流，因此请遵循你的直觉。</p>
</div><ul>
<li>A great starting point for your Morgan Stanley research is our analysis highlighting 4 key rewards and 3 important warning signs that could impact your investment decision.</li>
<li>Our free Morgan Stanley research report provides a comprehensive fundamental analysis summarized in a single visual - the Snowflake - making it easy to evaluate Morgan Stanley's overall financial health at a glance.</li>
</ul>
<div class="lb-trans"><ul>
<li>开始你的摩根士丹利研究的一个好起点是我们的分析，突出了 4 个关键回报和 3 个可能影响你投资决策的重要警示信号。</li>
<li>我们的免费摩根士丹利研究报告提供了全面的基本面分析，汇总在一个视觉图中——雪花图，使你能够一目了然地评估摩根士丹利的整体财务健康状况。</li>
</ul>
</div><h2>No Opportunity In Morgan Stanley?</h2>
<div class="lb-trans"><h2>摩根士丹利没有机会？</h2>
</div><p>Our daily scans reveal stocks with breakout potential. Don't miss this chance:</p>
<div class="lb-trans"><p>我们的每日扫描揭示了具有突破潜力的股票。不要错过这个机会：</p>
</div><ul>
<li>AI is about to change healthcare. These 32 stocks are working on everything from early diagnostics to drug discovery. The best part - they are all under $10b in market cap - there's still time to get in early.</li>
<li>Uncover the next big thing with 27 elite penny stocks that balance risk and reward.</li>
<li>The latest GPUs need a type of rare earth metal called Neodymium and there are only 30 companies in the world exploring or producing it. Find the list for free.</li>
</ul>
<div class="lb-trans"><ul>
<li>人工智能即将改变医疗保健。这 32 只股票正在从早期诊断到药物发现等各个方面进行研发。最棒的是——它们的市值都在 100 亿美元以下——还有时间提前布局。</li>
<li>揭示 27 只平衡风险和回报的精英便士股票的下一个大机会。</li>
<li>最新的 GPU 需要一种叫做钕的稀土金属，全球只有 30 家公司在探索或生产它。免费获取名单。</li>
</ul>
</div><p><em>This article by Simply Wall St is general in nature. <strong>We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice.</strong> It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.</em></p>
<div class="lb-trans"><p><em>本文由 Simply Wall St 撰写，内容具有一般性。<strong>我们提供基于历史数据和分析师预测的评论，采用无偏见的方法，我们的文章并不旨在提供财务建议。</strong> 这并不构成买入或卖出任何股票的推荐，也未考虑你的目标或财务状况。我们旨在为你提供以基本数据驱动的长期分析。请注意，我们的分析可能未考虑最新的价格敏感公司公告或定性材料。Simply Wall St 在提到的任何股票中没有持仓。</em></p>
</div><h3><strong>New:</strong> Manage All Your Stock Portfolios in One Place</h3>
<div class="lb-trans"><h3><strong>新功能：在一个地方管理所有股票投资组合</strong></h3>
</div><p>We've created the <strong>ultimate portfolio companion</strong> for stock investors, <strong>and it's free.</strong></p>
<div class="lb-trans"><p>我们为股票投资者创建了 <strong>终极投资组合助手</strong>，<strong>而且是免费的。</strong></p>
</div><p>• Connect an unlimited number of Portfolios and see your total in one currency</p>
<div class="lb-trans"><p>• 连接无限数量的投资组合，并以一种货币查看你的总额</p>
</div><p>• Be alerted to new Warning Signs or Risks via email or mobile</p>
<div class="lb-trans"><p>• 通过电子邮件或手机接收新的警示信号或风险提示</p>
</div><p>• Track the Fair Value of your stocks</p>
<div class="lb-trans"><p>• 跟踪你股票的公允价值</p>
</div><p>Try a Demo Portfolio for Free</p>
<div class="lb-trans"><p>免费试用演示投资组合</p>
</div>

How Investors Are Reacting To Morgan Stanley (MS) Earnings Beat And Optimistic AI-Driven Outlook

Simplywall

Parametric Equity Plus ETF

Calvert US Large-Cap Core Responsible Index ETF

Calvert US Large-Cap Diversity Equity & Inclusion Index ETF

金融指数 MSCI ETF - Fidelity

Eaton Vance Intermediate Municipal Income ETF

金融业 ETF - SPDR

Calvert Ultra-Short Investment Grade ETF

金融业 ETF - Vanguard

Eaton Vance Ultra-Short Income ETF

Calvert US Mid-Cap Core Responsible Index ETF

Parametric Hedged Equity ETF

Parametric Equity Premium Income ETF

Morgan Stanley Pathway Sm-Md Cp Eq ETF

Eaton Vance High Yield ETF

Calvert International Responsible Index ETF

美国经纪商&证券交易所 ETF - iShares

Calvert US Select Equity ETF

Morgan Stanley Pathway Large Cap Eq ETF

MORGAN STANLEY DEP SHS EA REP 1/1000 SHS NON CUM PFD O

MORGAN STANLEY DEP SHS REPSTG 1/1000TH PFD SER Q

MORGAN STANLEY DEP SHS REPS 1/1000 7.125% PFD E

MORGAN STANLEY NON-CUM DEP SH REP 1/1000 PFD SER I

MORGAN STANLEY 4.875 DEP SHS REP 1/1000 NCUM PFD SR L

MORGAN STANLEY 6.5%DEP SHS REPSTG 1/1000 NON CUM SER P

MORGAN STANLEY DEP SHS REPS 1/1000 PFD SER 'A'

MORGAN STANLEY DEP SHS REPR 1/1000TH INT PFD SER 'F' FX

MORGAN STANLEY DEP SHS REP 1/1000 NON-CUM PFD STK SER K

投资者如何应对摩根士丹利（MS）盈利超预期以及乐观的人工智能驱动前景